EVFM Evofem Biosciences, Inc. Stock Quote

EVFM [NASD]

Index	-	P/E	-	EPS (ttm)	-1.93	Insider Own	1.30%	Shs Outstand	81.21M	Perf Week	5.95%
Market Cap	230.02M	Forward P/E	-	EPS next Y	-1.36	Insider Trans	-8.83%	Shs Float	79.94M	Perf Month	17.77%
Income	-114.40M	PEG	-	EPS next Q	-0.36	Inst Own	45.20%	Short Float	14.62%	Perf Quarter	13.10%
Sales	0.30M	P/S	766.74	EPS this Y	65.40%	Inst Trans	0.46%	Short Ratio	4.73	Perf Half Y	-1.38%
Book/sh	0.50	P/B	5.70	EPS next Y	29.50%	ROA	-157.10%	Target Price	-	Perf Year	-45.19%
Cash/sh	1.08	P/C	2.65	EPS next 5Y	-	ROE	-365.00%	52W Range	1.91 - 7.21	Perf YTD	18.26%
Dividend	-	P/FCF	-	EPS past 5Y	42.70%	ROI	-	52W High	-60.47%	Beta	-0.07
Dividend %	-	Quick Ratio	1.50	Sales past 5Y	-	Gross Margin	21.90%	52W Low	49.21%	ATR	0.17
Employees	53	Current Ratio	1.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	66.09	Volatility	5.86% 6.98%
Optionable	Yes	Debt/Eq	1.20	EPS Q/Q	-23.40%	Profit Margin	-	Rel Volume	0.86	Prev Close	2.93
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 09 AMC	Payout	-	Avg Volume	2.47M	Price	2.85
Recom	2.00	SMA20	8.75%	SMA50	19.81%	SMA200	-9.86%	Volume	2,113,433	Change	-2.73%

Oct-02-20

Initiated

Stifel

Buy

Aug-20-20

Initiated

Morgan Stanley

Equal-Weight

Jun-08-20

Initiated

Piper Sandler

Overweight

$11

Oct-16-19

Resumed

Cantor Fitzgerald

Overweight

Jan-12-21 09:05AM	Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021 PR Newswire
Dec-22-20 07:00AM	Evofem Biosciences to Participate in Medicaid National Drug Rebate Program for Phexxi® Effective January 1, 2021 PR Newswire +12.56%
Dec-21-20 09:00AM	Evofem Biosciences to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference PR Newswire
Dec-17-20 07:00AM	Evofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea PR Newswire
Dec-12-20 03:12PM	Is EVFM A Good Stock To Buy Now? Insider Monkey
Dec-11-20 08:00AM	Evofem Biosciences Announces Orange Book Listing of Two U.S. Patents for Phexxi® PR Newswire
Dec-03-20 07:00AM	The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi® PR Newswire
Nov-20-20 08:30AM	Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference PR Newswire
Nov-12-20 08:30AM	Evofem Biosciences to Present at Stifel Virtual Healthcare Conference PR Newswire
Nov-09-20 11:00PM	Evofem Biosciences, Inc. (EVFM) Q3 2020 Earnings Call Transcript Motley Fool
04:01PM	Evofem Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update PR Newswire
03:15PM	Evofem Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Oct-27-20 08:00AM	Evofem Biosciences to Report Third Quarter 2020 Results and Provide Corporate Update on Monday, November 9, 2020 PR Newswire
Oct-26-20 09:00AM	Evofem Biosciences to Participate in Virtual Investor KOL Roundtable PR Newswire
Oct-20-20 08:00AM	Evofem Biosciences Announces First Patient Enrolled in Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea PR Newswire -6.38%
Oct-08-20 10:15AM	Unusual Options Activity Insight: Evofem Biosciences Benzinga
Oct-07-20 08:00AM	Evofem Biosciences Announces Presentations on Phexxi and EVO100 at Key Medical Society Meetings PR Newswire +5.19%
Sep-16-20 12:13PM	Evofem Biosciences Announces Updated Date and Time for Fireside Chat at Cantor Global Virtual Healthcare Conference PR Newswire
Sep-14-20 09:42AM	Is the Options Market Predicting a Spike in Evofem Biosciences (EVFM) Stock? Zacks +11.90%
09:00AM	Evofem Biosciences to Present Data at the 2020 STD Prevention Virtual Conference from Phase 2b Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in Women PR Newswire
Sep-11-20 12:02PM	Why Evofem Biosciences Stock Is Plunging Today Motley Fool -22.79%
10:27AM	Return On Capital Employed Overview: Evofem Biosciences Benzinga
Sep-07-20 11:57AM	What Is The Ownership Structure Like For Evofem Biosciences, Inc. (NASDAQ:EVFM)? Simply Wall St.
Aug-31-20 09:00AM	Evofem Biosciences to Participate in Four Upcoming Investor Conferences PR Newswire +6.07%
Aug-21-20 06:00PM	Evofem Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
Aug-20-20 09:51AM	Benzinga's Top Upgrades, Downgrades For August 20, 2020 Benzinga
Aug-11-20 08:53AM	Do Options Traders Know Something About Evofem Biosciences (EVFM) Stock We Don't? Zacks
Aug-04-20 09:31PM	Evofem Biosciences, Inc. (EVFM) Q2 2020 Earnings Call Transcript Motley Fool -5.63%
08:00AM	Evofem Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update PR Newswire
Aug-03-20 08:30AM	Evofem Biosciences' CEO Saundra Pelletier Named to PharmaVOICE100 - The Most Inspiring People in Life Sciences PR Newswire +7.02%
Jul-23-20 08:30AM	Evofem Biosciences to Report Second Quarter 2020 Results and Provide Corporate Update on Tuesday, August 4, 2020 PR Newswire
Jul-21-20 03:55AM	Edited Transcript of EVFM.OQ earnings conference call or presentation 6-Aug-19 3:00pm GMT Thomson Reuters StreetEvents
03:55AM	Edited Transcript of EVFM.OQ earnings conference call or presentation 7-Nov-19 4:00pm GMT Thomson Reuters StreetEvents
Jul-15-20 08:30AM	Evofem Biosciences Announces Peer-Reviewed Publication of the Pivotal Phase 3 AMPOWER Study Results For Phexxi (lactic acid, citric acid and potassium bitartrate) in Contraception PR Newswire
Jul-01-20 08:01AM	Evofem Biosciences Issues Mid-Year 2020 Letter to Stockholders PR Newswire +8.48%
Jun-29-20 09:33AM	Are Options Traders Betting on a Big Move in Evofem Biosciences (EVFM) Stock? Zacks
Jun-26-20 08:44AM	Evofem Biosciences (EVFM) Looks Good: Stock Adds 10.1% in Session Zacks -5.56%
Jun-12-20 08:08AM	Edited Transcript of EVFM earnings conference call or presentation 6-May-20 3:00pm GMT Thomson Reuters StreetEvents
Jun-03-20 12:31PM	Why Evofem Biosciences Is Down Today Motley Fool -26.61%
Jun-02-20 11:03PM	Evofem Announces Pricing of Approximately $100 Million Public Offering of Common Stock PR Newswire -7.91%
04:01PM	Evofem Announces Proposed Public Offering of Common Stock PR Newswire
May-31-20 05:15PM	Is Evofem Biosciences, Inc. (EVFM) A Good Buy According To Hedge Funds? Insider Monkey
May-28-20 06:30AM	Finally, Some Good News for Evofem Biosciences Motley Fool -6.75%
May-27-20 10:56AM	Company News for May 27, 2020 Zacks
08:55AM	Are Options Traders Betting on a Big Move in Evofem Biosciences (EVFM) Stock? Zacks
May-26-20 10:32AM	A Look Into Evofem Biosciences' Price Over Earnings Benzinga +16.03%
09:52AM	Evofem Biosciences Soars as Birth-Control Gel Receives FDA OK TheStreet.com
09:00AM	Why Evofem Biosciences Stock Is on Fire Today Motley Fool
08:42AM	Evofem Biosciences Rallies on Contraceptive Gel Approval: What's Next? TheStreet.com
May-22-20 04:37PM	Evofem stock rallies as FDA approves birth-control gel MarketWatch
04:05PM	U.S. FDA Approves Evofem Biosciences' Phexxi (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of Pregnancy PR Newswire
01:09PM	Birth Control Gel Approved as First No-Hormone Option in Decades Bloomberg
01:07PM	Evofem's gel first non-hormonal contraceptive to get approval in over 30 years Reuters
01:07PM	Evofem non-hormonal birth control gel gets FDA approval, to be priced at up to $275 Reuters
May-21-20 04:05PM	PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders PR Newswire
May-18-20 04:05PM	PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL Stockholders PR Newswire
May-13-20 08:00AM	Evofem Biosciences to Participate in Virtual Fireside Chat at RBC Capital Markets Global Healthcare Conference PR Newswire
May-08-20 09:00AM	PDL Biopharma Inc (PDLI) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 07:30AM	Evofem Biosciences, Inc. (EVFM) Q1 2020 Earnings Call Transcript Motley Fool
May-06-20 08:00AM	Evofem Biosciences Reports First Quarter 2020 Financial Results and Provides Corporate Update PR Newswire
May-01-20 05:21PM	Evofem Biosciences Announces New Location and COVID-19 Preventative Measures for 2020 Annual Meeting Scheduled for May 12, 2020 PR Newswire +5.49%
Apr-28-20 08:00AM	Evofem Biosciences to Report First Quarter 2020 Results and Provide Corporate Update on Wednesday, May 6, 2020 PR Newswire -7.50%
Apr-24-20 08:30AM	Evofem Biosciences Announces Three New Phexxi Data Sets Accepted for Presentation at the 2020 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting PR Newswire
Apr-19-20 07:02AM	3 Top Biotech Stocks with FDA Approvals on the Horizon TipRanks
Apr-10-20 04:05PM	Evofem Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
Mar-30-20 05:14PM	Edited Transcript of EVFM earnings conference call or presentation 12-Mar-20 3:00pm GMT Thomson Reuters StreetEvents +7.96%
Mar-27-20 08:30AM	Evofem Biosciences to Present at Solebury Trout Virtual Investor Conference PR Newswire
Mar-25-20 05:00PM	Evofem Biosciences Adopts Shareholder Rights Agreement PR Newswire
Mar-24-20 04:00PM	Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies ACCESSWIRE +11.05%
Mar-19-20 08:15AM	TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors GlobeNewswire +11.90%
Mar-12-20 09:00AM	Evofem Biosciences, Inc. to Host Earnings Call ACCESSWIRE -23.06%
08:00AM	Evofem Biosciences Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Corporate Update PR Newswire
Mar-09-20 11:53AM	We're Keeping An Eye On Evofem Biosciences's (NASDAQ:EVFM) Cash Burn Rate Simply Wall St. -12.48%
Feb-26-20 08:30AM	Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick, M.D., to its Board of Directors PR Newswire
Feb-16-20 08:25AM	3 Monster Growth Stocks That Can Charge Forward in 2020 TipRanks
Dec-22-19 05:32PM	Hedge Funds Have Never Been This Bullish On Evofem Biosciences, Inc. (EVFM) Insider Monkey
Dec-18-19 07:30AM	U.S. FDA Acknowledges Receipt of Evofem Biosciences' New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy PR Newswire
Dec-03-19 09:00AM	PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Candidate Amphora® PR Newswire
07:59AM	The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial Benzinga
Dec-02-19 08:07AM	Benzinga Pro's Top 5 Stocks To Watch For Mon., Dec. 2, 2019: EVFM, AQMS, ROKU, TDOC, COUP Benzinga +12.27%
07:18AM	UPDATE: Evofem Biosciences stock soars 27% premarket on news of positive results in trial of drugs for STDs MarketWatch
06:50AM	Evofem Biosciences Reports Positive Top-Line Results from Phase 2b Study of Amphora® for Prevention of Chlamydia and Gonorrhea in Women PR Newswire
Nov-24-19 04:19PM	The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Arrowhead Earnings And More Benzinga
Nov-14-19 08:00AM	Evofem Biosciences' CEO Saundra Pelletier Awarded 2019 Business Woman Of The Year PR Newswire
Nov-13-19 04:05PM	Evofem Biosciences to Participate in Upcoming Investor Conferences PR Newswire
Nov-08-19 08:30PM	Avid Technology, Callon Petroleum, Orion Group, and Other 13D Filings Barrons.com
Nov-07-19 11:26AM	PDL BioPharma (PDLI) Q3 Earnings Beat, LENSAR Drives Sales Zacks
Nov-06-19 04:05PM	Evofem Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Oct-24-19 09:00AM	Evofem Biosciences to Report Third Quarter 2019 Results and Provide Corporate Update on November 7, 2019 PR Newswire
Sep-25-19 09:00AM	Evofem Biosciences to Present at Cantor Global Healthcare Conference on October 4, 2019 PR Newswire
Sep-11-19 01:31PM	What Type Of Shareholder Owns Evofem Biosciences, Inc.'s (NASDAQ:EVFM)? Simply Wall St.
Aug-26-19 06:00AM	Evofem Biosciences Completes Phase 2b 'AMPREVENCE' Trial of Amphora for Prevention of Chlamydia and Gonorrhea in Women PR Newswire
Aug-22-19 09:30AM	Evofem Biosciences to Present at Upcoming Healthcare Conferences PR Newswire
Aug-08-19 11:23AM	PDL Biopharma Inc (PDLI) Q2 2019 Earnings Call Transcript Motley Fool +6.20%
10:17AM	PDL BioPharma (PDLI) Q2 Earnings Top Mark, Revenues Fall Y/Y Zacks
Aug-05-19 04:10PM	Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
04:05PM	Evofem Biosciences Reports Additional Data from Phase 3 'AMPOWER' Study of Amphora® for Hormone-Free Birth Control PR Newswire
Jul-30-19 09:00AM	Evofem Biosciences to Report Second Quarter 2019 Results and Provide Corporate Update on August 6, 2019 PR Newswire
Jul-01-19 09:31AM	Evofem Biosciences Added to Russell 3000® Index PR Newswire -14.91%
Jun-10-19 04:01PM	Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors PR Newswire

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
File Justin J.	Chief Financial Officer	Nov 17	Buy	2.17	7,760	16,839	258,168	Nov 18 05:22 PM
Fitzpatrick Alexander A	General Counsel and Secretary	Nov 17	Buy	2.20	9,090	19,998	143,542	Nov 18 05:14 PM
Barrans Russell	Chief Commercial Officer	Sep 11	Buy	2.08	3,000	6,240	279,052	Sep 11 05:20 PM
Barrans Russell	Chief Commercial Officer	Sep 10	Buy	2.71	1,000	2,710	276,052	Sep 11 05:20 PM
PELLETIER SAUNDRA L	Chief Executive Officer	Sep 08	Sale	3.26	122,500	399,350	360,888	Sep 10 08:04 PM
Rarick Lisa Dale	Director	Jun 17	Buy	2.99	5,250	15,698	5,250	Jun 18 04:29 PM
Hall William Walmsley	Director	Jun 15	Buy	2.85	5,000	14,250	5,000	Jun 17 08:38 PM
File Justin J.	Chief Financial Officer	Jun 12	Buy	3.14	8,500	26,690	250,408	Jun 15 04:16 PM
Kamdar Kim P.	Director	Jun 12	Buy	2.94	5,000	14,700	9,287	Jun 16 04:35 PM
Invesco Ltd.	10% Owner	Jun 05	Buy	3.50	857,143	3,000,001	13,226,532	Jun 09 06:49 AM
Link Fund Solutions Ltd	10% Owner	Jun 04	Sale	0.23	9,138,504	2,101,856	0	Jul 17 11:11 AM
ACACIA RESEARCH CORP	10% Owner	Jun 04	Sale	3.21	9,138,504	29,325,459	1,000	Jun 09 09:08 PM
Invesco Ltd.	10% Owner	May 26	Sale	5.79	73,879	427,772	12,369,389	Jun 09 06:49 AM
Invesco Ltd.	10% Owner	May 15	Sale	5.04	3,211	16,183	12,443,268	Jun 09 06:49 AM
Culwell Kelly	Chief Medical Officer	May 01	Sale	4.75	1,000	4,750	194,226	May 01 08:12 PM
Culwell Kelly	Chief Medical Officer	Apr 30	Sale	4.66	1,000	4,660	195,226	May 01 08:12 PM
Lynch Thomas G	Director	Mar 31	Option Exercise	0.00	37,500	0	325,000	Apr 01 04:11 PM
Barrans Russell	Chief Commercial Officer	Feb 19	Sale	6.50	14,957	97,221	332,240	Feb 21 02:10 PM
Culwell Kelly	Chief Medical Officer	Feb 19	Sale	7.00	1,000	7,000	196,226	Feb 21 02:10 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience